DeepIntent Fine-Tunes Tech to Optimize Ad Campaigns, Boost Script Lift

DeepIntent announced it has received a patent for its DeepIntent Outcomes™ technology, a platform that aims to increase script lift and boost business outcomes for marketers.

In this article for MM+M, DeepIntent’s CEO Chris Paquette highlights how DeepIntent has integrated measurement capabilities directly into the platform, and uses machine learning to optimize pricing and targeting in real time.

Read more here

More News

Article
Connected TV works ‘harder and smarter’ for the ad dollar, new analysis finds
As more and more people flock to streaming channels over traditional TV, pharma ad dollars are following them. In this article for Fierce Pharma,...
Read More
Hands typing on laptop with a line graph on screen
Article
Tapping new tech helps marketers matchmake rare disease drugs for elusive patients
Treating rare diseases is challenging enough, so you can imagine how difficult it is to reach the right healthcare audiences with info about specialty...
Read More
2022 image
Article
Pharma marketing 2022: More digital shifts for reps, ads and drug launches, plus reputation and the metaverse
What trends can healthcare marketers expect in 2022? In this article for Endpoints News, CEO Chris Paquette discusses how pharma brands will be increasing...
Read More